Fuji Pharma Co (FRA:FUP) EV-to-FCF: (As of Jun. 30, 2026)


FRA:FUP Fuji Pharma Co Ltd FRA:FUP
85 GF Score
Price €10.60
GF Value €9.59
! 3 Warning Signs
View Full Analysis

What is Fuji Pharma Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Fuji Pharma Co's Enterprise Value is €383.1 Mil. Fuji Pharma Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil. Therefore, Fuji Pharma Co's EV-to-FCF for today is .

The historical rank and industry rank for Fuji Pharma Co's EV-to-FCF or its related term are showing as below:

FRA:FUP' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 37.69
Current: 37.69

During the past 13 years, the highest EV-to-FCF of Fuji Pharma Co was 37.69. The lowest was 0.00. And the median was 0.00.

FRA:FUP's EV-to-FCF is ranked worse than
68.64% of 558 companies
in the Drug Manufacturers industry
Industry Median: 20.045 vs FRA:FUP: 37.69

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-06-30), Fuji Pharma Co's stock price is €10.60. Fuji Pharma Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.566. Therefore, Fuji Pharma Co's PE Ratio (TTM) for today is 18.73.


Fuji Pharma Co  (FRA:FUP) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Fuji Pharma Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.60/0.566
=18.73

Fuji Pharma Co's share price for today is €10.60.
Fuji Pharma Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.566.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Fuji Pharma Co EV-to-FCF Related Terms


Fuji Pharma Co EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Fuji Pharma Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuji Pharma Co EV-to-FCF Chart

Fuji Pharma Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.59 -3.53 -27.76 -251.68 31.59

Fuji Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 31.59 0.00 0.00

FRA:FUP vs ZTS, UTHR: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuji Pharma Co EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Fuji Pharma Co's EV-to-FCF falls into.


FRA:FUP
85GF Score
Fuji Pharma Co Ltd FRA:FUP
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuji Pharma Co EV-to-FCF Calculation

Fuji Pharma Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=383.100/0
=

Fuji Pharma Co's current Enterprise Value is €383.1 Mil.
Fuji Pharma Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of €10.60 is trading 10.5% above its estimated GF Value™ of €9.59.

Key valuation signals for FRA:FUP:

  • EV-to-FCF:
  • GF Value™: €9.59 vs. price of €10.60 (10.5% above fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fuji Pharma Co Business Description

Other Exchanges 4554:Japan
Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
85GF Score

Get the complete analysis for FRA:FUP

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.60
Price
€9.59
GF Value